Related Experiment Video
Updated: Jul 13, 2025
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Interaction between mitochondria and microbiota modulating cellular metabolism in inflammatory bowel disease
Misa Hirose1, Priyadharshini Sekar2, Mariam Wed Abdelaziz Eladham2
1Lübeck Institute of Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.
Mitochondria and gut microbes play key roles in inflammatory bowel disease (IBD) pathogenesis. Understanding their interaction may reveal new therapeutic targets for IBD treatment.
Area of Science:
- Gastroenterology
- Cell Biology
- Microbiology
Background:
- Inflammatory bowel disease (IBD) is a complex gastrointestinal disorder with increasing incidence.
- Mitochondria and intestinal microbiota are implicated in IBD pathogenesis.
- The interplay between mitochondria and gut microbes may influence disease activity.
Purpose of the Study:
- To review the roles of mitochondria and intestinal microbiota in IBD.
- To explore the intercommunication between mitochondria and the gut microbiome in IBD patients.
- To identify novel therapeutic strategies for IBD based on these interactions.
Main Methods:
- Literature review of experimental and clinical observations.
- Analysis of the roles of mitochondria and microbiota in IBD.
- Focus on cellular metabolism in intestinal and immune cells.
Main Results:
- Mitochondria and gut microbiota are critical in IBD development.
- Interactions between mitochondria and gut microbes modulate disease-related cellular activities.
- Specific mediators of these interactions are identified.
Conclusions:
- Dissecting the mitochondrial-microbiota interaction offers insights into IBD pathways.
- This understanding can lead to novel therapeutic approaches for IBD.
- Targeting these interactions may improve treatment outcomes and patient quality of life.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...